Mylan NV

( )
MYL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Generic
ZTSZoetis, Inc. 1.60%132.491.9%$314.30m
TEVATeva Pharmaceutical Industries Ltd. 0.65%12.402.0%$156.79m
MYLMylan NV 1.18%16.333.2%$109.00m
BBIOBridgeBio Pharma, Inc. 0.91%35.320.0%$17.01m
RDYDr. Reddy's Laboratories Ltd. -0.93%50.932.0%$10.95m
TXMDTherapeuticsMD, Inc. 0.82%1.2322.1%$8.05m
ABEOAbeona Therapeutics, Inc. 2.30%3.124.5%$3.81m
TAROTaro Pharmaceutical Industries Ltd. 0.35%69.326.5%$2.20m
LFVNLifeVantage Corp. 2.76%15.293.3%$2.01m
COCPCocrystal Pharma, Inc. -0.99%1.000.0%$1.84m
KINKindred Biosciences, Inc. 8.39%5.170.3%$1.58m
JAGXJaguar Health, Inc. -1.15%0.432.0%$0.67m
CPHIChina Pharma Holdings, Inc. -2.34%0.460.1%$0.46m

Company Profile

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.